(NASDAQ:CLNN), As the U.S. Food and Drug Administration (FDA) proposed, Clene is concluding analyses of its ALS biomarker data with completion planned shortly The FDA advised Clene to request a Type C meeting to review these further ALS biomarker data analyses The Company plans to submit a New Drug Application (NDA) in the first quarter […]
VANCOUVER, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) — The holidays just got easier with Club Kitchen, an innovative new way to enjoy your favourite meals from multiple restaurants all in one convenient order. Providing the perfect meal for multiple people can be a major chore, and considering many different preferences and opinions can make
(NASDAQ:SNYR), WESTBROOK, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, is announcing its financial results for the three months ended September 30, 2025. “We are pleased to report our 11th quarter of profitability and double-digit revenue growth, accompanied by over
CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — A study by the Society of Actuaries (SOA) Research Institute found that fentanyl and synthetic opioids continue to be a leading cause of overdose deaths in the U.S., despite drug-related mortality decreasing in 2023 and provisional data suggesting a further decrease in 2024. The SOA Research Institute also
(NASDAQ:HUMA), DURHAM, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the details of six presentations on the Company's acellular tissue engineered vessel (ATEV(TM)) that are scheduled for the 52nd Annual Symposium on Vascular and Endovascular Issues,
(NASDAQ:OXLCO),(NasdaqGM:OXLC),(NASDAQ:OXLCP),(NASDAQ:OXLCL),(NASDAQ:OXLCZ),(NASDAQ:OXLCN),(NASDAQ:OXLCI),(NASDAQ:OXLCG), GREENWICH, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (the “Company,” “we,” or “our”) today announced the following net asset value (“NAV”) estimate as of October 31, 2025. Management's unaudited estimate of the range of
MIAMI, Nov. 13, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., a leading medical technology company, developing and delivering innovative allografts for musculoskeletal and wound-care applications, today announced the publication of a new peer-reviewed study titled “Comparative evaluation of skin substitutes for diabetic foot ulcers and venous leg ulcers using the Medicare Administrative Claims Database.” This
(CNSX:BOIL.CN),(OTC US:BEOLF),(Other OTC:BEOLF),(Boerse Frankfurt – Freiverkehr:UH9),(Boerse Frankfurt – Freiverkehr:UH9.F),(TSX:BOIL), VANCOUVER, British Columbia and KIBBUTZ YIFAT, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) — Beyond Oil Ltd. (TSX:BOIL) (OTCQB:BEOLF) (“Beyond Oil” or the “Company“), a food-tech innovation company dedicated to reducing health risks associated with fried food while lowering operational costs, minimizing waste, and enhancing sustainability, announced
(NASDAQ:BTM),(NASDAQ:BTMWW), Q3 Revenue up 20% Year-Over-Year to $162.5 Million Q3 Net Income up 139% Year-Over-Year to $5.5 Million Q3 Gross Profit up 40% Year-Over-Year to $28.2 Million Q3 Adjusted EBITDA up 75% Year-Over-Year to $16.1 Million ATLANTA, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bitcoin Depot (Nasdaq: BTM) (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin
(NASDAQ:CINGW),(NASDAQ:CING), Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply Agreement Executed KANSAS CITY, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release(TM) (PTR(TM)) drug delivery platform to build a pipeline of next-generation products, today announced